Qualified, Resourced and Genuinely Available

Part of Principal Investigator (PI) Training: The Investigator's Accountability.

About 4 minutes. Free, in your language, no account needed.

Why this matters

Two of the shortest sub-sections in the guideline cause a disproportionate share of investigator findings. Section 2.1 asks whether you are qualified. Section 2.2 asks whether you have what the trial needs — including time. The second is the one physicians routinely get wrong, because agreeing to a trial takes five minutes and running one takes three years.

Qualified — and able to prove it

Section 2.1 requires the investigator to be qualified by education, training and experience to assume responsibility for the proper conduct of the trial, and to provide evidence of those qualifications.

In practice, the evidence is a small, boring, permanently current set of documents:

The failure mode is almost never that a physician is unqualified. It is that the file says a CV was signed four years ago and a license expired last March. Set a single annual date on which every investigator and sub-investigator at your site refreshes all of it, and the problem disappears.

Section 2.1 also requires familiarity with the appropriate use of the investigational product, as described in the protocol and the current Investigator's Brochure. "Familiar" is not "have received". When the Brochure is updated mid-trial — and it will be — the update is a document you read, not a document you file.

Resourced — the honest feasibility answer

Section 2.2 is about whether the trial can actually run where you are. Two sub-points do most of the work.

§2.2.1 — participants. You should be able to demonstrate a potential for recruiting the required number of suitable participants within the agreed period. The guideline explicitly contemplates supporting this with retrospective or currently available data. This is the antidote to the most common site failure in clinical research: the enthusiastic estimate.

Do the arithmetic before you sign, not after. Take the last twelve months of your own clinic. Apply the protocol's inclusion criteria, then its exclusion criteria, then a realistic proportion who will consent. The number that survives is your honest estimate. It is nearly always a fraction of the first number that came to mind.

§2.2.2 — time, staff and facilities. You should have sufficient time to properly conduct and complete the trial, and adequate numbers of qualified staff and adequate facilities for its foreseen duration.

"Sufficient time" is a regulatory requirement, not a courtesy. It is the sub-point that quietly underlies supervision findings, late safety reporting and unsigned data. An investigator who cannot find an hour a week for a trial will produce a site that looks fine for six months and then does not.

The time audit nobody does

Before agreeing to a trial, price your own time in it. A reasonable rough model for a site running a moderate interventional study:

ActivityRealistic investigator time
Protocol, Brochure and amendment reading3–6 hours at start-up, then 1–2 hours per amendment
Eligibility review and sign-off15–30 minutes per screened participant
Medical review of visits, labs and events1–3 hours per week once enrolling
Adverse event assessment15–45 minutes per event, unpredictable in timing
Data review and endorsement at agreed milestonesSeveral hours per milestone
Monitoring visits, audits, inspectionsHalf a day to a day, several times a year

None of these is optional and none of them can be moved to a coordinator. If the total does not fit in your week, the correct answer at feasibility is no — or a sub-investigator with real, protected time.

Declining a trial you cannot run is a professional act, not a failure. It is far cheaper than a site closed for non-compliance, and it is the only version of §2.2.2 that is honest.

Key takeaways